Patient specific treatment planning for systemically administered radiopharmaceuticals using PET/CT and Monte Carlo simulation.

@article{Grudzinski2010PatientST,
  title={Patient specific treatment planning for systemically administered radiopharmaceuticals using PET/CT and Monte Carlo simulation.},
  author={J. Grudzinski and H. Yoriyaz and P. Deluca and J. Weichert},
  journal={Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine},
  year={2010},
  volume={68 1},
  pages={
          59-65
        }
}
  • J. Grudzinski, H. Yoriyaz, +1 author J. Weichert
  • Published 2010
  • Medicine
  • Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
  • The efficacy of systemically administered radiopharmaceuticals depends on the physiological path of the targeting molecule and the physical characteristics of the attached radionuclide. NM404 is a candidate for patient specific dosimetry because it can be used concurrently for both diagnosis and therapy. Radiolabeling NM404 with [(124)I] affords the possibility of performing noninvasive PET imaging while [(131)I] allows for radiotherapy. Patient specific dosimetry for radiation treatment… CONTINUE READING
    7 Citations

    References

    SHOWING 1-10 OF 48 REFERENCES
    Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study.
    • 35
    The impact of PET and SPECT on dosimetry for targeted radionuclide therapy.
    • 101
    • Highly Influential
    • PDF
    Options for radionuclide therapy: from fixed activity to patient-specific treatment planning.
    • S. Thomas
    • Medicine
    • Cancer biotherapy & radiopharmaceuticals
    • 2002
    • 31
    • PDF
    Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
    • 263
    • PDF
    A quality-control method for SPECT-based dosimetry in targeted radionuclide therapy.
    • 17
    Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.
    • 140
    • PDF
    Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy.
    • 105
    • Highly Influential
    Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET
    • 129
    Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems
    • 76
    Targeted radionuclide therapy.
    • 60
    • PDF